<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03814213</url>
  </required_header>
  <id_info>
    <org_study_id>90-days mortality</org_study_id>
    <nct_id>NCT03814213</nct_id>
  </id_info>
  <brief_title>Effect of Comprehensive Geriatric Assessment on Short-time Mortality in Elderly Cancer Patients</brief_title>
  <official_title>Effect of Comprehensive Geriatric Assessment on Short-time Mortality in Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Older cancer patients referred to Oncology outpatient Clinic at Aarhus University Hospital&#xD;
      have for a period been offered Comprehensive geriatric Assessment (CGA) as part of a routine&#xD;
      practice. Oncology Department was responsible for planning the CGA. A number of patients did&#xD;
      however not recieve this offer as planning failed. This Group of patients will be compared to&#xD;
      patients recieving Geriatric assessment.&#xD;
&#xD;
      Patients recieving CGA is part of a Randomised controlled study (ID: NCT02837679) comparing&#xD;
      CGA without 90 days follow-up to CGA with 90 days of Comprehensive geriatric care.&#xD;
&#xD;
      Patients are identified from electronic medical files. Data regarding death is obtained from&#xD;
      Medical files.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria:&#xD;
&#xD;
        -  70 years or more&#xD;
&#xD;
        -  Cancer of the head and neck (HNC), lung (LC), upper gastro-intestinal- tract (UGI) or&#xD;
           colo-rectal cancer (CRC)&#xD;
&#xD;
        -  Referred to the Outpatient Clinic at department of oncology at Aarhus University&#xD;
           Hospital for cancer treatment.&#xD;
&#xD;
        -  Living in Aarhus, Favrskov, Odder or Skanderborg Municipalities&#xD;
&#xD;
      Exclusion:&#xD;
&#xD;
      - Referred for specialised palliative care&#xD;
&#xD;
      Patients with both newly diagnosed cancer disease and patients with a relapse of previously&#xD;
      treated cancer disease are included. Patients qualify for participation regardless of the&#xD;
      stage of the cancer disease and regardless if specific cancer treatment is initiated.&#xD;
&#xD;
      The oncology department is responsible for identifying patients and informing of the planned&#xD;
      CGA.&#xD;
&#xD;
      All potential patients referred to the oncology outpatient clinic are identified by&#xD;
      retrospective review of lists of planned consultations in the oncology department out patient&#xD;
      clinic available in the electronic medical file approximately once a week. By this procedure&#xD;
      patients who were not informed of the possibility of having a CGA are identified (Group1)&#xD;
      Patients who are referred for geriatric evaluation have a complete CGA at baseline. The CGA&#xD;
      comprises 7 instruments for assessing health: Activities of Daily Living (ADL) and&#xD;
      Instrumental Activities of Daily Living (IADL) for autonomy, Mini Nutritional Status (MNA)&#xD;
      for nutritional state, Mini Mental State Examination (MMSE) for Cognitive state, Geriatric&#xD;
      Depression Scale 15-item (GDS) for mood and Cumulative Illness Rating Scale - Geriatrics&#xD;
      (CIRS-G) for comorbidity and number of daily medication for polypharmacy as previously&#xD;
      published. According to CGA, patients were given a CGA-status of &quot;fit&quot;, &quot;vulnerable&quot; or&#xD;
      &quot;frail&quot;. In order to be &quot;fit&quot; all of the following should be present: Independence in ADL and&#xD;
      IADL, less than 5 daily medications, no severe comorbidity and no more than 2 well controlled&#xD;
      comorbidities, normal cognitive ability and no indications of depression or malnutrition.&#xD;
      Information on whether or not the multidisciplinary team initiated any individual&#xD;
      action/advice based on the CGA in group 1 and group 2 was registered as well. Interventions&#xD;
      initiated by the multidisciplinary team were recorded in four categories: medical changes,&#xD;
      nutritional intervention, physical intervention or social intervention. These interventions&#xD;
      were registered before randomization was performed Frail and vulnerable patients are offered&#xD;
      participation in a controlled randomized study (Clinical trialsID: NCT02837679). Patients are&#xD;
      randomly and 1:1 assigned to either: No tailored follow-up (Group 2) or 90 days tailored&#xD;
      follow up (group 3). Randomization were performed by REDcap and allocated equally by&#xD;
      CGA-status (frail/vulnerable), gender and index tumor site (CRC or no-CRC).&#xD;
&#xD;
      It is not possible to blind patients or the multidisciplinary team of the randomization.&#xD;
&#xD;
      Group 2 has no tailored follow up on the problems found during CGA. Group 3 has 90 days&#xD;
      tailored follow-up on problems that were identified during CGA and problems that evolved&#xD;
      during the follow-up period.&#xD;
&#xD;
      Tailored follow-up The tailored intervention consists of phone calls, home visits, or contact&#xD;
      to community care-takers. A multidisciplinary team consisting of a trained geriatric nurse&#xD;
      and a geriatrician specialist performs the follow up. The team can perform clinical&#xD;
      investigation of patients, initiate changes in medication, or referral to further&#xD;
      investigation. Furthermore transfusion of blood, fluids or i.v. antibiotics could be&#xD;
      performed either at home or in the geriatric out patient clinic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 16, 2019</start_date>
  <completion_date type="Actual">April 25, 2019</completion_date>
  <primary_completion_date type="Actual">April 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>short time mortality</measure>
    <time_frame>90 days</time_frame>
    <description>dead within 90 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>1 year mortality</measure>
    <time_frame>365 days</time_frame>
    <description>dead within 1 year</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">781</enrollment>
  <condition>Geriatric Assessment</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>No-CGA</arm_group_label>
    <description>Patients were not initially offered CGA due to no booking for CGA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CGA alone</arm_group_label>
    <description>Patients had CGA, but no tailored follow-up upon identified problems</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CGA with tailored care</arm_group_label>
    <description>CGA and a tailored follow-up and care for 90 days following the CGA</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CGA</intervention_name>
    <description>Multi-level Health assessment</description>
    <arm_group_label>CGA alone</arm_group_label>
    <arm_group_label>CGA with tailored care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>tailored care</intervention_name>
    <description>Tailored care based on problems identified by CGA</description>
    <arm_group_label>CGA with tailored care</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        older cancer patients referred for oncology out patient Clinic for evaluaation regarding&#xD;
        initialisation of treatment All stages of cancer is included, all kind of treatment is&#xD;
        accepted including best supportive care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        cancer of head and neck, lung, upper or lower gastro intestinal Canal Referred for&#xD;
        evaluation in oncology department out patient Clinic Living in Aarhus, Odder, Favrskov or&#xD;
        Skanderborg municipality&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Referred for specialised palliative care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Else M Damsgaard, DMsc</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geriatric Department Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000 C</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>January 22, 2019</study_first_submitted>
  <study_first_submitted_qc>January 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2019</study_first_posted>
  <last_update_submitted>April 25, 2019</last_update_submitted>
  <last_update_submitted_qc>April 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Marianne Ã˜rum</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Comprehensive geriatric assessment</keyword>
  <keyword>Cancer</keyword>
  <keyword>Short time mortality</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

